In DepthU.S. Policy

Regulators drop controversial biospecimen consent proposal

See allHide authors and affiliations

Science  27 Jan 2017:
Vol. 355, Issue 6323, pp. 335
DOI: 10.1126/science.355.6323.335

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

U.S. biomedical researchers have fought off a feared rule change that would have made it more difficult and expensive to study anonymous blood and tissue samples taken from patients. Proposed in 2015, the controversial change was dropped 2 days before former President Barack Obama left office, when federal officials released a long-awaited update to the so-called Common Rule that protects human participants in studies. The update also hands scientists a second victory, by blunting a 2014 law that researchers say had hamstrung studies using blood spots obtained from newborns. The 543-page rule, released 18 January, does include other changes, including lighter ethics reviews for certain studies, that scientists welcome.